Algo version: 0.98b
UTHR is listed at the NASDAQ Exchange
UTHR [UTHR]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is UTHR stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for United Therapeutics Corp 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $114.93, you would have made a profit of $230.52 per share or 200.57%

Yes, the average daily trading liquidity for United Therapeutics Corp is $160.34 million. You should therefore be able to get in and out of your positions relatively fast.

United Therapeutics Corp has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.63, the company's ability to pay off the debt is good. United Therapeutics Corp has a very good net profit margin of 42.05% and should have very high tolerances against inflation.

We have calculated the inflation risk for United Therapeutics Corp to be low [0 out of 1]